COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...


Research Triangle Ventures, a venture capital firm, specialized in investing in seed and early stage technology companies located in North Carolina.